Cargando…

The role of platelet-lymphocyte ratio in hepatocellular carcinoma: a valuable prognostic marker

Detalles Bibliográficos
Autores principales:	Chan, Kai Siang, Shelat, Vishal G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834588/ https://www.ncbi.nlm.nih.gov/pubmed/36644176 http://dx.doi.org/10.21037/tcr-22-2343

Ejemplares similares

Role of inflammatory indices in management of hepatocellular carcinoma—neutrophil to lymphocyte ratio
por: Shelat, Vishal G.
Publicado: (2020)

Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma
por: Kabir, T., et al.
Publicado: (2019)

Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma
por: Song, Wei, et al.
Publicado: (2016)

Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer
por: You, Jie, et al.
Publicado: (2016)

Is there a role for percutaneous needle aspiration in the multimodal management of pyogenic liver abscess?
por: Chan, Kai Siang, et al.
Publicado: (2023)

Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
por: Zhao, Yongzhao, et al.
Publicado: (2017)

Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Ma, Wencong, et al.
Publicado: (2016)

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
por: Oh, Dongwook, et al.
Publicado: (2018)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization
por: Jeong, Soung Won
Publicado: (2020)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
por: Wu, Yue Linda, et al.
Publicado: (2022)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

NLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
por: Zhang, Xiu-Wen, et al.
Publicado: (2020)

Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, De-Zhao, et al.
Publicado: (2022)

Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
por: Zhong, Zhi-Han, et al.
Publicado: (2023)

Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
por: Shen, Yanjun, et al.
Publicado: (2019)

Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma
por: Giakoustidis, Alexandros, et al.
Publicado: (2018)

Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases
por: Thio, Quirina C. B. S., et al.
Publicado: (2018)

Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma
por: Yapar, Aliekber, et al.
Publicado: (2021)

Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
por: Solmaz, Serife, et al.
Publicado: (2018)

Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis
por: Lin, Wan-fu, et al.
Publicado: (2018)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with COVID-19
por: Piovani, Daniele, et al.
Publicado: (2022)

The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis
por: Zeb, Alam, et al.
Publicado: (2019)

The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
por: He, Chaobin, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023)

Prognostic Significance of Platelet-to-Lymphocyte Ratio (PLR) in Extrahepatic Metastasis of Hepatocellular Carcinoma After Curative Resection
por: Chen, Yifan, et al.
Publicado: (2021)

Prognostic role of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio for hospital mortality in patients with AECOPD
por: Yao, CaoYuan, et al.
Publicado: (2017)

Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer
por: Wang, Jianfeng, et al.
Publicado: (2017)

The prognostic role of the preoperative platelet to lymphocyte ratio in laryngeal cancer
por: Li, Qin, et al.
Publicado: (2023)

Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma
por: Chen, Kai, et al.
Publicado: (2018)

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma
por: Hu, Zuojian, et al.
Publicado: (2019)

Diagnosis, severity stratification and management of adult acute pancreatitis–current evidence and controversies
por: Chan, Kai Siang, et al.
Publicado: (2022)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma
por: Jiang, Yanming, et al.
Publicado: (2018)

The Effects of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Prognostic Markers in Determining the Mortality in Patients Diagnosed With Pneumonia in Intensive Care
por: Altas, Omer Faruk, et al.
Publicado: (2021)

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection()
por: Liao, Weijia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0kilhh46i8cqep7jhko4c6nkul